2 52 Running title: Loss of UGP2 causes a severe epileptic encephalopathy 53 54 55 Abstract: 60 Developmental and/or epileptic encephalopathies (DEEs) are a group of devastating genetic 61 disorders, resulting in early onset, therapy resistant seizures and developmental delay. Here we 62 report on 12 individuals from 10 families presenting with a severe form of intractable epilepsy, 63 severe developmental delay, progressive microcephaly and visual disturbance. Whole exome 64 sequencing identified a recurrent, homozygous variant (chr2:64083454A>G) in the essential UDP-65 glucose pyrophosphorylase (UGP2) gene in all probands. This rare variant results in a tolerable 66
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Having identified at least 12 individuals with an almost identical clinical phenotype and an identical 168 homozygous variant in the same gene, led us to pursue UGP2 as a candidate gene for a new genetic 169 form of DEE. UGP2 is highly expressed in various brain regions (Figure 1F) , and also widely expressed 170 amongst other tissues, including liver and muscle according to the data from the GTEx portal 35 171 5 (Supplementary Figure 1D) . The (chr2:64083454A>G) variant is predicted to cause a missense variant 172 (c.34A>G, p.Met12Val) in UGP2 isoform 1 (NM_006759), and to cause a translation start loss (c.1A>G, 173 p.?.) of UGP2 isoform 2 (NM_001001521), referred to as long and short isoform, respectively. The 174 variant has not been reported in the Epi25 web browser 36 , ClinVar 37 , LOVD 38 , Exome Variant Server 39 , 175 DECIPHER 40 , GENESIS 41 , GME variome 42 or Iranome databases 43 , is absent from our in-house data 176 bases and is found only 15 times in a heterozygous, but not homozygous, state in the 280,902 alleles 177 present in gnomAD (MAF: 0.00005340) 44 . In the GeneDx unaffected adult cohort, the variant was 178 found heterozygous 10 times out of 173,502 alleles (MAF: 0.00005764), in the ~10,000 exomes of the 179
Queen Square Genomic Center database two heterozygous individuals were identified, and out of 180 45,921 individuals in the Centogene cohort, 10 individuals are heterozygous for this variant. The 181
identified variant has a CADD score (v1.4) of 19.22 45 and Mutation Taster 46 predicted this variant as 182 disease causing. The nucleotide is strongly conserved over multiple species (Figure 1G) . Analysis of 183 WES data from 6 patients did provide evidence of a shared ROH between patients from different 184 families, indicating that this same variant might represent an ancient mutation that originated some 185 26 generations ago (Supplementary Figure 1C) . Interestingly, since most families originally came 186 from regions of India, Pakistan and Iran, overlapping with an area called Balochistan, this could 187
indicate that the mutation has originated there around 600 years ago. As Dutch traders settled in 188 that area in the 17 th century, it is tempting to speculate that this could explain the co-occurrence of 189 the variant in these distant places 47 . 190 Short UGP2 isoform is predominantly expressed in brain and absent in patients with ATG mutations 191 Both UGP2 isoforms only differ by 11 amino acids at the N-terminal (Figure 2A) and are expected to 192 be functionally equivalent 8 . To investigate how the A>G variant may cause DEE, we first obtained 193 fibroblasts from individual 1 (homozygous for the A>G variant) and her heterozygous parents and 194 analyzed the isoform expression by Western blotting (Figure 2B) . Whereas the two isoforms were 195 equally expressed in wild type fibroblasts, the expression of the shorter isoform was diminished to 196 ~25% of total UGP2 in heterozygous parents, both of individual 1 (Figure 2B , C) and of individual 2 197 and 3 (Supplementary figure 2A, B) , and was absent in cells from the affected individual 1 (Figure 2  198 B, C; fibroblasts of the affected children in family 2 or other families were not available). Total UGP2 199 levels were not significantly different between the affected child and her parents, or between 200 parents and wild type controls (Figure 2D, Supplementary Figure 2C ). This indicates that the long 201 isoform harboring the Met12Val missense variant is upregulated in fibroblast when the short isoform 202 is missing. Moreover, this indicates that Met12Val does not affect the stability of the long isoform at 203 the protein or transcript level (Supplementary Figure 2D, E, F) . RNA-seq on peripheral blood samples 204 of family 1 did not identify altered splicing events of UGP2 and the global transcriptome of the 205 proband was not different from her parents, although only a limited analysis could be performed as 206 only a single sample was available for each individual (Supplementary Figure 2G, H) . Both 207 homozygous and heterozygous fibroblasts had a similar proliferation rate compared to wild type 208 fibroblasts (Figure 2E, Supplementary Figure 2I) , and immunocytochemistry confirmed a similar 209 subcellular localization of UGP2 in mutant and wild type cells (Figure 2F) . We then measured the 210 enzymatic activity of UGP2 in wild type, heterozygous and homozygous fibroblasts, and found that 211 mutant fibroblast had a similar capacity to produce UDP-glucose in the presence of exogenously 212 supplied glucose-1-phosphate and UTP (Figure 2G) . Altogether, this indicates that the long UGP2 213 isoform harboring the Met12Val missense change is functional and is therefore unlikely to contribute 214 to the patient phenotype. 215 6 As the A>G variant results in a functional long UGP2 isoform but abolishes the translation of the 216 shorter UGP2 isoform, we next investigated whether the ratio between short and long isoform 217 differs amongst tissues. If so, the homozygous A>G variant would lead to depletion of UGP2 in tissues 218
where mainly the short isoform is expressed, possibly below a threshold that is required for normal 219 development or function. Western blotting on cellular extracts derived from wild type H9 human 220 embryonic stem cells (ESCs), commercially acquired H9-derived neural stem cells (NSCs) and 221 fibroblasts ( Figure 3A) showed that, whereas the ratio between short and long isoform in fibroblasts 222 was around 0.5, in ESCs it was 0.14 and in NSCs 0.77, indicating that the shorter UGP2 isoform is the 223 predominant one in NSCs (Figure 3B) . A similar trend was observed when assessing the transcript 224 level, both by multiplex RT-PCR and RT-qPCR, using primers detecting specifically the short and long 225 transcript isoform (Figure 3C, D, E) . This indicates that differential isoform expression between cell 226
types is regulated at the transcriptional level, possibly hinting at tissue-specific regulatory elements 227 driving isoform expression. We next analyzed RNA-seq data from human fetal tissues 48-51 to 228 determine the fraction of reads covering short versus total UGP2 transcripts ( Figure 3F) . This showed 229 that in human fetal brain the short transcript isoform is predominantly expressed. To gain more 230 insight into the cell type-specific expression of UGP2, we performed immunohistochemistry on 231 human fetal brain tissues from the first to third trimester of pregnancy ( Figure 3G ). In the 232 first trimester we found pale labeling of neuropil in the proliferative neuroepithelium of the 233 hypothalamic, cortical, mesencephalic and thalamic regions ( Figure 3G indicates that UGP2 can be detected in a broad variety of cell types during brain development. On 246
Western blotting, we noticed preferential expression of the shorter UGP2 isoform in the developing 247 cortex and cerebellum from gestational weeks 14, 20 and 28 ( Figure 3H ) and in the frontal cortex of 248 brains from weeks 21 and 23 (Supplementary Figure 2J) . Together, this supports the hypothesis that 249 the DEE phenotype in patients is caused by a major loss of functional UGP2 in the brain, as the short 250 isoform represents virtually all UGP2 produced in this tissue. 251
Lack of the short UGP2 isoform leads to transcriptome changes upon differentiation into neural stem 252 cells 253
To model the disease in vitro, we first engineered the homozygous A>G mutation in H9 ESCs to study 254 the mutation in a patient independent genetic background and compare it to isogenic parental cells. 255 We obtained two independent clones harboring the homozygous A>G change (referred to as knock-256 in, KI, mutant) and two cell lines harboring an insertion of an additional A after nucleotide position 42 257 of UGP2 transcript 1 (chr2:64083462_64083463insA) (Supplementary Figure 3A, B ) (referred to as 258 knockout, KO). This causes a premature stop codon at amino acid position 47 (D15Rfs*33), leading to 259 7 nonsense mediated mRNA decay and complete absence of UGP2 protein (Supplementary Figure 3C) . 260 All derived ESCs had a normal morphology and remained pluripotent as assessed by marker 261 expression ( Supplementary Figure 3D, Figure 5F ), but when 279 comparing wild type and KO cells, we observed noticeable changes, that were less pronounced in KI 280
NSCs but still followed a similar trend (Figure 4A, B, Supplementary Figure 5D , E). Gene enrichment 281 analysis showed that genes downregulated in KO and KI cells were implicated in processes related to 282 the extra-cellular matrix, cell-cell interactions and metabolism, while genes upregulated in KO and KI 283 cells were enriched for synaptic processes and genes implicated in epilepsy ( Figure 4C , 284 Supplementary Table 4 ). Both KO and KI cells showed an upregulation of neuronal expressed genes, 285
indicating a tendency to differentiate prematurely. To validate RNA-seq findings, we tested several 286 genes by RT-qPCR in wild type, KI and KO cells ( Figure 4D ). We also included KO rescue cells, in which 287
we had restored the expression of either the wild type or the mutant UGP2 long isoform, leading 288 each to an approximately 4-fold UGP2 overexpression at the NSC state compared to WT 289 (Supplementary Figure 4F) . Amongst the tested genes was NNAT, which showed a significant 290 upregulation in KI and KO cells, which was rescued by restoration of UGP2 expression in KO NSCs.
291
NNAT encodes neuronatin that stimulates glycogen synthesis by upregulating glycogen synthase and 292
was previously found to be upregulated in Lafora disease. This lethal teen-age onset 293 neurodegenerative disorder presenting with myoclonic epilepsy is caused by mutations in the 294 ubiquitin ligase malin, leading to accumulation of altered polyglucosans 54 . Malin can ubiquitinate 295 neuronatin leading to its degradation. As reduced UGP2 expression might impact on glycogen 296 production, it seems plausible that this results in compensatory NNAT upregulation and in 297 downstream aberrations contributing to the patient phenotypes. Indeed, neuronatin upregulation 298 was shown to cause increased intracellular Ca 2+ signaling, ER stress, proteasomal dysfunction and cell 299 death in Lafora disease 55, 56 , and was shown to be a stress responsive protein in the outer segment of 300 retina photoreceptors 57,58 . Another interesting gene upregulated in KI and KO NSCs and 301 downregulated in rescue cell lines was the autism candidate gene FGFBP3 59 . This secreted 302 proteoglycan that enhances FGF signaling is broadly expressed in brain 60 , and functions as an 303 8 extracellular chaperone for locally stored FGFs in the ECM, thereby influencing glucose metabolism 304 by regulating rate-limiting enzymes in gluconeogenesis 61 . Other potentially relevant genes displaying 305 the same expression trend were the heparan sulphate proteoglycan GPC2 (a marker of immature  306 neurons 62,63 ), the helix-loop-helix transcription factor ID4 (a marker of postmitotic neurons 64 ), and 307 the signaling molecule FGFR3 that has been implicated in epilepsy 65 . Genes downregulated in KO 308 cells and upregulated in rescue cells included urokinase-type plasminogen activator PLAU (deficiency 309 in mouse models increases seizure susceptibility 66 ), the glycoprotein GALNT7 (upregulation of which 310 has been found to promote glioma cell invasion 67 ) and the brain tumor gene MYBL1 (that has been 311 shown to be regulated by O-linked N-acetylglucosamine 68 . Similar expression changes were observed 312 in NSCs differentiated from induced pluripotent stem cells (iPSCs) that we had generated from family 313 1 (Supplementary Figure 6) . Together, RNA-seq showed that whereas the absence of UGP2 is 314 tolerated in ESCs, its complete absence or reduced expression results in global transcriptome 315 changes in NSCs, with many affected genes implicated in DEE relevant pathways. 316 317
Absence of short UGP2 isoform leads to metabolic defects in neural stem cells 318
To investigate how reduced UGP2 expression levels in KO and KI cells would impact on NSC 319 metabolism, we investigated the capacity to produce UDP-glucose in the presence of exogenously 320 supplied glucose-1-phospate and UTP. KO NSCs showed a severely reduced ability to produce UDP-321 glucose ( Figure 5A ). This reduction was rescued by ectopic overexpression of both long wild type and 322 long mutant UGP2. KI cells showed a slightly reduced activity in ESCs (Supplementary Figure 7A) , but 323 a more strongly reduced activity in NSCs compared to wild type (Figure 5A) , correlating with total 324 UGP2 expression levels (Supplementary Figure 4D, E) . Surprisingly, contrary to KO NSCs, KO ESC 325 showed some residual capacity to produce UDP-glucose despite the complete absence of UGP2 326 (Supplementary Figure 7A) . This could indicate that a yet to be identified enzyme can partially take 327 over the function of UGP2 in ESCs but not NSCs, which might explain the lack of expression changes 328 in this cell type upon UGP2 loss. iPSCs showed similar results (Supplementary Figure 7B) . We next 329 assessed the capacity to synthesize glycogen under low oxygen conditions by PAS staining, as it was 330 previously shown that hypoxia triggers increased glycogen synthesis 69 . As expected, wild type ESCs 331 cultured for 48 hours under hypoxia showed an intense cytoplasmic PAS staining in most cells 332 (Supplementary Figure 7C , D), while KO ESCs showed a severely reduced staining intensity. This 333
indicates that under hypoxia conditions, the residual capacity of ESC to produce UDP-glucose in the 334 absence of UGP2 is insufficient to produce glycogen. KI ESCs were indistinguishable from wild type 335 (Supplementary Figure 7D) . At the NSC state, many KO cells kept at low oxygen conditions for 48 336 hours died (data not shown) and those KO cells that did survive were completely depleted from 337 glycogen granules (Figure 5B, C) . This could be rescued by overexpression of both wild type or 338 mutant long UGP2 isoform. KI NSCs showed a more severe reduction in PAS staining compared to the 339 ESC state (Figure 5B, C) , and we observed similar findings in patient iPSC derived NSCs 340 (Supplementary Figure 7E) . Together, this further indicates that upon neural differentiation the 341 isoform expression switch renders patient cells depleted of UGP2, leading to a reduced capacity to 342 synthesize glycogen. This can directly be involved in the DEE phenotype, as, besides affecting energy 343 metabolism, reduction of glycogen in brain has been shown to result in I) impairment of synaptic 344 plasticity 70 ; II) reduced clearance of extracellular potassium ions leading to neuronal 345 hypersynchronization and seizures 71-73 ; and III) altered glutamate metabolism 74 . To investigate how 346 9 reduced UDP-glucose levels would impact on glycosylation, we next, investigated glycosylation levels 347 by means of LAMP2, a lysosomal protein known to be extensively glycosylated both by N-linked and 348
O-linked glycosylation 75 . We found that KO NSCs show hypoglycosylation of LAMP2 that is rescued by 349 the over expression of both WT and mutant long isoform ( Figure 5D ). In contrast, in ESCs no 350 glycosylation defects were noticed (Supplementary Figure 7F ). Finally, we investigated whether the 351 absence of UGP2, affecting protein glycosylation, could induce ER stress and thus unfolded protein 352 response (UPR). Whereas in ESCs, the absence of UGP2 did not result in a detectable effect on UPR 353 markers (Supplementary Figure 7G) , in NSCs we noticed an increased expression of these genes both 354
in KO and in KI cells (Figure 5E ). This indicates that NSCs having UGP2 levels under a certain threshold 355 are more prone to ER-stress and UPR. In agreement with this, we did not observe upregulation of 356 UPR markers in patient derived fibroblast, which have similar total UGP2 expression levels compared 357
to controls (Supplementary Figure 7H ). Together this indicates that upon differentiation to NSCs, KI 358 cells become sufficiently depleted of UGP2 to have reduced synthesis of UDP-glucose, leading to 359 defects in glycogen synthesis and protein glycosylation and to the activation of UPR response. 360
Alterations of these crucial processes are likely to be implicated in the pathogenesis leading to 361 increased seizure susceptibility, altered brain microstructure and progressive microcephaly. 362
Ugp2a and Ugp2b double mutant zebrafish recapitulate metabolic changes during brain 363 development, have an abnormal behavioral phenotype, visual disturbance, and increased seizure 364 susceptibility 365 Finally, to model the consequences of the lack of UGP2 in vivo, we generated zebrafish mutants for 366 both ugp2a and ugp2b, the zebrafish homologs of UGP2, using CRISPR-Cas9 injections in fertilized 367 oocytes in a background of a radial glia/neural stem cell reporter 76 . Double homozygous mutant lines 368 having frameshift deletions for both genes confirmed by Sanger sequencing could be generated but 369 the only viable combination, obtained with ugp2a loss, created a novel ATG in exon 2 of ugp2b, 370 leading to a hypomorphic allele ( Figure 6A ). Homozygous ugp2a/b mutant zebrafish had a normal 371 gross morphology of brain and radial glial cells (Figure 6B) , showed a largely diminished activity to 372 produce UDP-glucose in the presence of exogenously supplied glucose-1-phospate and UTP ( Figure  373 6C), and showed a reduction in c-FOS expression levels, indicating reduced global neuronal activity 374 ( Figure 6D ). To monitor possible spontaneous seizures, we performed video tracking experiments of 375 developing larvae under light-dark cycling conditions at 5 days post fertilization (dpf). Control larvae 376
show increased locomotor activity under light conditions, and although ugp2 double mutant larvae 377 still responded to increasing light conditions, they showed a strongly reduced activity (Figure 6E, F) . 378 This could indicate that their capability to sense visual cues is diminished, or that their tectal 379 processing of visual input is delayed, resulting in reduced movements. Strikingly, upon careful 380 inspection, we noticed that ugp2 double mutant larvae did not show spontaneous eye movements, 381 in contrast to age-matched control larvae (Figure 6G , Supplemental Movie 1 and 2). Whereas we did 382 not observe an obvious spontaneous epilepsy phenotype in these double mutant larvae, upon 383 stimulation with 4-aminopyridine (4-AP), a potent convulsant, double mutant larvae showed an 384 increased frequency and duration of movements at high velocity compared to controls, which might 385
indicate an increased seizure susceptibility (Figure 6H, I) . Taken together, severely reduced 386
Ugp2a/Ugp2b levels result in a behavior defect with reduced eye movements, indicating that also in 387 zebrafish Ugp2 plays an important role in brain function. 388 UGP2 is an essential gene in humans and ATG mutations of tissue specific isoforms of essential genes 389 potentially cause more rare genetic diseases 390 Several lines of evidence argue that UGP2 is essential in humans. First, no homozygous LoF variants 391 or homozygous exon-covering deletions for UGP2 are present in gnomAD or GeneDx controls, and 392 homozygous variants in this gene are limited to non-coding changes, synonymous variants and 5 393 missense variants, together occurring only 7 times homozygous ( Supplementary Table 5 severe downregulation of GATA2 compared to wild type cells, and this was restored in rescue cell 407 lines ( Figure 7A ). GATA2 is a key transcription factor in the developing blood system, and knockout of 408
Gata2 is embryonic lethal in mice due to defects in HSC generation and maintenance 94,95 . 409
Differentiation of ESCs into cardiomyocytes similarly affected key marker gene expression in KO cells, 410
and these changes were restored upon UGP2 rescue (Figure 7B, C) . Whereas WT ESCs could generate 411 beating cardiomyocytes after 10 days, these were not seen in KO ESCs. Taken together this argues 412 that the complete absence of UGP2 in humans is probably incompatible with life, a hypothesis that 413 cannot be tested directly. However, if true, this could well explain the occurrence of the unique 414 recurrent mutation in all cases presented herein. Given the structure of the UGP2 locus (Figure 2A) , 415 every LoF variant would affect either the long isoform, when located in the first 33 nucleotides of the 416 cDNA sequence, or both the short and long isoform when downstream to the ATG of the short 417 isoform. Therefore, the short isoform start codon is the only mutational target that can disrupt 418 specifically the short isoform. In this case, the Met12Val change introduced into the long isoform 419
does not seem to disrupt UGP2 function to such an extent that this is intolerable and therefore 420 allows development to proceed for most tissues. However, the lack of the short UGP2 isoform 421 caused by the start codon mutation results in a depletion of functional UGP2 in tissues where 422 normally the short isoform is predominantly expressed. In brain this reduction diminishes total UGP2 423 levels below a threshold for normal development, causing a severe epileptic encephalopathy 424 syndrome. Given the complexity of the human genome with 42976 transcripts with RefSeq peptide 425
IDs, perhaps also other genetic disorders might be caused by such tissue restricted depletion of 426 essential proteins. Using a computational homology search of human proteins encoded by different 427 isoforms, we have identified 1766 genes that share a similar structure to the UGP2 locus (e.g. a 428
shorter protein isoform that is largely identical to the longer protein isoform, translated from an ATG 429 that is contained within the coding sequence of the long isoform) ( Figure 7D ). When filtering these 430 genes for 1) those previously shown to be essential 6 , 2) not associated with disease (e.g. no OMIM 431 phenotype) and 3) those proteins where the shorter isoform is no more than 50 amino acids 432 11 truncated at the N-terminal compared to the longer isoform, we identified 247 genes 433
( Supplementary Table 6 ). When comparing the ratios of isoform specific reads obtained from 434 different fetal RNA-seq data 48-51 we noticed that many of these genes show differential isoform 435 expression amongst multiple tissues, with many genes showing either expression of the long or the 436 short isoform in a particular tissue ( Figure 7E ). Homozygous LoF variants or start codon altering 437 mutations in these genes are rare in gnomAD ( Supplementary Table 7) , and it is tempting to 438 speculate that mutations in start codons of these genes could be associated with human genetic 439 diseases, as is the case for UGP2. Using mining of data from undiagnosed patients from our own 440 exome data base, the Queen Square Genomic Center database and those from Centogene and 441
GeneDx, we found evidence for several genes out of the 247 having rare, bi-allelic variants affecting 442
the start codon of one of the isoforms that could be implicated in novel disorders (unpublished 443
observations) and give one such example in the Supplementary Note. Together, these findings 444
highlight the relevance of mutations resulting in tissue-specific protein loss of essential genes for 445 genetic disorders. Here we describe a recurrent variant in 12 individuals from 10 families, affecting the start codon of 464 the shorter isoform of the essential gene UGP2 as a novel cause of a severe DEE. Using in vitro and in 465 vivo disease modeling, we provide evidence that the reduction of UGP2 expression in brain cells 466 leads to global transcriptome changes, a reduced ability to produce glycogen, alterations in 467 glycosylation and increased sensitivity to ER stress, which together can explain the phenotype 468 observed in the patients. Most likely our findings in vitro underestimate the downstream effects in 469 patient cells, as in fetal brain the longer isoform expression is almost completely silenced and 470 virtually all UGP2 comes from the shorter isoform, which in patient cells cannot be translated. During 471 our in vitro NSC differentiation this isoform switch is less complete, leaving cells with the patient 472 mutation with some residual UGP2. Strikingly, the clinical phenotype seems to be very similar in all 473 cases, including intractable seizures, absence of developmental milestones, progressive microcephaly 474 and a disturbance of vision, with retinal pigment changes observed in all patients who had 475 undergone ophthalmological examination. Also, all patients seem to share similar, although mild, 476 dysmorphisms, possibly making this condition a recognizable syndrome. 477
The involvement of UGP2 in genetic disease is surprising. Given its central role in nucleotide-sugar 478 metabolism it is expected that loss of this essential protein would be incompatible with life, and 479 therefore loss-of-function should not be found in association with postnatal disease. Our data argue 480 that indeed a total absence of UGP2 in all cells is lethal, but that tissue-specific loss, as caused here 481 by the start codon alteration of an isoform important for brain, can be compatible with postnatal 482 development but still results in a severe phenotype. Given that any other LoF variant across this gene 483 would most likely affect both protein isoforms, this could also explain why only a single mutation is 484
found in all individuals. The fact that the Met12Val long isoform was able to rescue the full KO 485 phenotype indicates that the missense change introduced to the long protein isoform does not affect 486 UGP2 function. As other variants at this start codon, even heterozygous, are not found, possibly 487 missense variants encoding for leucine, lysine, threonine, arginine or isoleucine (e.g. amino acids that 488 would be encoded by alternative changes affecting the ATG codon) at this amino acid location in the 489 long isoform could not produce a functional protein and are therefore not tolerated. Although start 490 codon mutations have previously been implicated in disease 96,97 , there are no reports, to our 491 knowledge, on disorders describing start codon alterations of other essential genes, leading to 492 alterations of tissue specific isoforms. Using a genome-wide homology search, we have identified a 493 large list of other essential genes with a similar locus structure and variable isoform expression 494 amongst tissues, where similar ATG altering variants could affect tissue-relevant expression. An 495
intriguing question is why evolution has resulted in a large number of genes encoding almost 496 identical protein isoforms. It will be interesting to further explore the mutational landscape of these 497 genes in cohorts of currently unexplained patients. preserved after spontaneous or induced abortions with appropriate maternal written consent for 589 brain autopsy and use of rest material for research. We performed a careful histological and 590 immunohistochemical analysis and evaluation of clinical data (including genetic data, when 591 available). We only included specimens displaying a normal cortical structure for the corresponding 592 age and without any significant brain pathology. 593
Brain tissue immunohistochemistry 594
For immunohistochemical analysis, we used 2 cases from the first trimester (GW6 and GW9), 4 cases 595 from the second trimester (GW21, GW23, GW24 and GW26) and 2 cases from the third trimester 596 (GW33 and GW36). Anatomical regions were determined according to the atlas of human brain 597 development [103] [104] [105] [106] . We cut 4 µm sections from formalin-fixed, paraffin embedded whole fetuses 598 (GW6 and GW9) and brain tissue from cerebral, mesencephalic, cerebellar and brain stem region 599
(from GW21 to GW36). Slides were stained with mouse anti-UGP2 (C-6) in a 1:150 dilution (Santa 600
Cruz) and visualized using Mouse and Rabbit Specific HRP/DAB (ABC) Detection IHC kit (Abcam Fibroblast cell culture 617 Fibroblasts from index patient 1 and her parents were obtained using a punch biopsy according to 618 standard procedures, upon informed consent (IRB approval MEC-2017-341). Fibroblasts from the 619 parents of index patient 2 and 3 were also obtained upon informed consent at McMaster Children's 620
Hospital. All fibroblasts were cultured in standard DMEM medium supplemented with 15% Fetal calf 621 serum, MEM Non-Essential amino acids (Sigma), 100 U/ml penicillin and 100 µg/ml streptomycin, as 622 done previously 108 , in routine humidified cell culture incubators at 20% O2. Fibroblast cell lines were 623 transfected using Lipofectamine 3000 (Invitrogen) with the indicated plasmid constructs. All the cell 624 lines used in this report were regularly checked for the presence of mycoplasma and were negative 625 during all experiments. 626
Genome engineering in human embryonic stem cells 627 H9 human embryonic stem cells were cultured as previously described 107,109 . In short, cells were 628 maintained on feeder free conditions in mTeSR-1 medium (STEMCELL technologies) on Matrigel 629
(Corning) coated culture dishes. To engineer the patient specific UGP2 mutation by homologous 630 recombination 110 , ESC were transfected using Lipofectamine 3000 with a plasmid expressing 631 eSpCas9-t2a-GFP (a kind gift of Feng Zhang) and a gRNA targeting the UGP2 gene (see 632
Supplementary Table 8 for the sequence), together with a 60 bp single stranded oligonucleotide 633 (ssODN) homology template encoding the patient mutation (synthesized at IDT). To increase the 634 stability of the ssODN and therefore homologous recombination efficiency, the first two 5' and 3' 635 nucleotides were synthesized using phosphorothiorate bonds 111 . 48 hours post transfection, GFP 636 expressing cells were sorted, and 6000 single GFP-positive cells were plated on a Matrigel coated 6-637 well plate in the presence of 10µM ROCK-inhibitor (Y27632, Millipore). After approximately 10 days, 638 single colonies where manually picked, expanded and genotyped using Sanger sequencing (see 639
Supplementary Table 8 for primer sequences). As a by-product of non-homologous end joining, 640
knock-out clones were identified which showed a single nucleotide A insertion at position 42 of UGP2 641 transcript 1 (chr2:64083462_64083463insA), leading to an out of frame transcript and a premature 642 termination of the protein at amino acid position 47 (D15Rfs*33). Western blotting confirmed the 643 absence of all UGP2 protein in knock-out clones and the loss of the short UGP2 isoform in clones with 644 the patient mutation. To produce a stable rescue cell line, ESC cells were transfected as previously 645
described with the pPyCAG-IRES-puro plasmid expressing either the long WT or mutant UGP2 646 isoform. After 48 hours, the population of cells with the transgene integration was selected with 647 1µg/ml puromycin. Engineered ESC clones had a normal colony morphology and pluripotency factor 648 expression. 649
Patient specific Induced pluripotent stem cell generation were assessed for their karyotype, pluripotency factor expression and three lineage differentiation 655 potential (Stem Cell Technologies, #05230), following the routine procedures of the Erasmus MC iPS 656 Cell facility, as previously described 108 . Sanger sequencing was used to verify the genotype of each 657 obtained iPSC line. We used three validated clones for each individual in our experiments. 658
Neural stem cell differentiation 659 Pluripotent cells were differentiated in neural stem cells (NSCs), using a modified dual SMAD 660 inhibition protocol 112 . In short, 18000 cells/cm 2 were plated on matrigel coated cell culture dishes in 661 mTeSR-1 medium in the presence of 10µM Y27632. When cells reached 90% confluency, the medium 662 was switched to differentiation medium (KnockOut DMEM (Gibco), 15% KnockOut serum 663 replacement (Gibco), 2mM L-glutamine (Gibco), MEM Non-Essential amino acids (Sigma), 0. 118 and Enrichr 119 were used to assess functional enrichment of differential 708 expressed genes. Supplementary Table 4 reports all outputs in LogP, log(q-value) and Adjusted p-709 value (q-value) for Metascape and g:profiler, and in p-value, Adjusted p-value (q-value) and 710 combined-score (which is the estimation of significance based on the combination of Fisher's exact 711 test p-value and z-score deviation from the expected rank) for Enrichr. All tools were used with 712 default parameters and whole genome set as background. 713
Genome-wide homology search: 714
To make a genome-wide list of transcripts sharing a similar structure as UGP2 transcripts, 42976 715 transcripts from 21522 genes (Human genes GRCh38.p12) were extracted using BioMart of Ensembl 716 (biomaRt R package). 11056 out of 21522 genes had only 1 transcript and the remaining 31920 717 transcripts from 10466 genes were selected, the protein sequences were obtained with biomaRt R 718 package and homology analysis was performed using the NCBI`s blastp (formatting option: -719 outfmt=6) command line. We grouped longest and shorter transcript based on coding sequence 720 length and only kept those that matched a pairwise homology comparison between the longest and 721 the shorter transcript with the following criteria: complete 100 percent identity, without any gap and 722 mismatch, and starting ATG codon of shortest transcript being part of the longest transcript(s). 1766 723 genes meet these criteria. We then filtered these genes for published essential genes 6 , leaving us 724 with 1197 genes. Using BioMart (Attributes: Phenotype description and Study external reference) of 725
Ensembl we then evaluated the probability that these genes were implicated in disease and 726 identified 850 genes that did not have an association with disease phenotype/OMIM number. Of 727 those, 247 genes encoded proteins of which the shorter isoform differed less than 50 amino acids 728 from the longer isoform. We chose this arbitrary threshold to exclude those genes where both 729 isoforms could encode proteins differing largely in size and might therefore encode functionally 730 completely differing proteins (although we cannot exclude that this will also hold true for some of 731 the genes in our selection). 732
Differential isoform expression in fetal tissues 733
Publically available RNA-seq data from various fetal tissue samples ( Supplementary Table 2 ) were 734 analyzed using the same workflow as described for the RNA-seq data analysis above. To determine 735 differential isoform expression in these tissues, we calculated a ratio between the unique exon(s) of 736 the shortest and longest transcript for each gene and assessed its variability across different fetal 737 tissue samples. The number of reads for each unique exon of a transcript was calculated by mapping 738 19 aligned RNA-seq reads against the unique exon coordinate using bedtools multicov. The longest and 739 shortest transcripts were separated and the transcript ratio (number of counts of shortest transcript 740 / (number of counts of shortest transcript + number of counts of longest transcript)) for each gene 741 was obtained from the average reads of RNA-seq samples per tissue. 382 genes out of 1197 genes 742 showed high variability across different samples (defined as a difference between highest and lowest 743 ratio > 0.5), 277 of those high variable genes were not associated with a disease phenotype/OMIM 744 number and of these 83 genes had a length less than 50 amino acids (a subset of the 247 genes with 745 no OMIM and length less than 50 amino acids) 746
Haplotype Analysis 747
The 30 MB region surrounding UGP2 was extracted from exome sequencing VCF files to include both 748 common and rare polymorphisms. Variants were filtered for a minimum depth of coverage of at least 749 10 reads and a genotype quality of at least 50. The filtered variants, were then used as input in PLINK 750 (v1.07) with the following settings: 751 --homozyg-snp 5 752 --homozyg-kb 100 753 --homozyg-gap 10000 754 --homozyg-window-het 0 755 ROH around the UGP2 variant were identified in all 5 probands examined. The minimum ROH in 756 common between all samples was a 5Mb region at chr2: 60679942-65667235. We note that targeted 757 sequencing leads to uneven SNP density, so the shared ROH may, in fact, be larger or smaller. Next, 758
we used recombination maps from deCODE to estimate the size of the region in centiMorgans (cM). 759 We then used the region size in cM to estimate the time to event in generations using methods 760 previously described 120 . 761 762 qPCR analysis 763 RNA was obtained using TRI reagent, and cDNA prepared using iSCRIPT cDNA Synthesis Kit according 764 to manufacturer's instructions. qPCR was performed using iTaq universal SYBR Green Supermix in a 765 CFX96RTS thermal cycler (Bio-Rad). Supplementary Table 8 summarizes all primers used in this 766 study. Relative gene expression was determined following the ΔΔct method. To calculate the ratio of 767 the short isoform, we performed absolute quantification as previously described 121 . Briefly, we 768 performed qPCR on known copy numbers, ranging from 10^3 to 10^8 copies, of a plasmid containing 769 the short UGP2 isoform (5' UTR included) using primers detecting specifically either the total or the 770 short isoform. After plotting the log copy number versus the ct, we obtained a standard curve that 771 we used to extrapolate the copy number of the unknown samples. For live imaging, the medium was changed at 1 dpf to E3 + 0.003% 1-phenyl 2-thiourea (PTU) to 791 prevent pigmentation. Ugp2a and ugp2b were targeted by Cas9/gRNA RNP-complex as we did 792 before 76 . Briefly, fertilized oocytes from a tgBAC(slc1a2b:Citrine)re01tg reporter line 76 maintained on 793
an TL background strain were obtained, and injected with Cas9 protein and crRNA and tracrRNA 794 synthesized by IDT (Alt-R CRISPR-Cas9 System), targeting the open reading frame of zebrafish ugp2a 795 and ugp2b. DNA was extracted from fin clips and used for genotyping using primers flanking the 796 gRNA location ( Supplementary Table 8 ) followed by sequencing. Mutants with a high level of out of 797 frame indels in both genes were identified using TIDE 122 and intercrossed to obtain germ line 798 transmission. Upon re-genotyping, mutant zebrafish with the following mutations as indicated in 799 Figure 6 were selected and further intercrossed. In this study, we describe two new mutant fish lines 800 containing deletions in ugp2a (ugp2a Δ/Δ ) and ugp2b (ugp2b Δ/Δ ): ugp2a re08/re08 containing a 37 bp 801 deletion in exon 2 and ugp2b re09/re09 containing a 5 bp deletion in exon 2. Intravital imaging, and 802 analysis of eye movement, was performed as previously described 76 . Briefly, zebrafish larvae 803 anesthetized in tricaine were mounted in low melting point agarose containing tricaine and imaged 804 using a Leica SP5 intravital imaging setup with a 20×/1.0 NA water-dipping lens. To assess the 805 locomotor activity of zebrafish larvae from 3 to 5 dpf, locomotor activity assays were performed 806 using an infrared camera system (DanioVision™ Observation chamber, Noldus) and using EthoVision® 807
XT software (Noldus) as described 76 Periodic acid, 15 min at 37°C with Schiff's reagent (Merck) and 5 min with Hematoxylin solution 818 21 (Klinipath) prior to air drying and mounting. Every step of the protocol is followed by a 10 minutes 819 wash with tap water. Imaging occurred on an Olympus BX40 microscope. Images were acquired at a 820 100x magnification, and ImageJ software was used for quantification. For ESCs, we used a minimum 821 of 20 images per genotype for the quantification, containing on average 20 cells each, calculating the 822 percentage of PAS positive area. For NSCs, we imaged between 80 to 100 cells per genotype, 823
counting the number of glycogen granules in the cytoplasm. We report the average of two 824 independent experiments at 48 hours low oxygen. 825 826 UGP2 enzymatic activity 827 The measurement of UGP2 enzyme activity was performed according to a modified GALT 828 enzyme activity assay as described previously 123 Figure 5D) . where ATG altering mutations could affect a tissue specific isoform causing genetic disease. Note the two separated isoforms of UGP2 that have a similar intensity in wild type cells. Pictures of patients will be made available upon publication of the peer-reviewed version of this preprint Transcript variant 1  NM006759  1527 bp, 509 AA   269  128  325  108  186 134  298 198 243  105  443   II III  IV  V  VI VII VIII  IX  X  Ia Ib Exon 
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